Principal Investigator
DAVIS, TERISA
Awardee Organization
UNIVERSITY OF ALABAMA AT BIRMINGHAM
United States
Fiscal Year
2013
Activity Code
N03
Project End Date
NIH RePORTER
For more information, see NIH RePORTER Project 261201200021I-0-26100004-1
Evaluation of GLG-302, a STAT3 Antagon
The primary goal of this task order is to determine whether GLG-302 (an inhibitor of STAT3 signaling) has cancer chemopreventive efficacy in preclinical models of breast cancer.